Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy.
This study describes morphological abnormalities of brain cells during acute methamphetamine (METH) intoxication in the rat and demonstrates the role of hyperthermia, disruption of the blood-brain barrier (BBB) and edema in their development. Rats with chronically implanted brain, muscle and skin temperature probes and an intravenous (i.v.) catheter were exposed to METH (9 mg/kg) at standard (23 degrees C) and warm (29 degrees C) ambient temperatures, allowing for the observation of hyperthermia ranging from mild to pathological (38-42 degrees C). When brain temperature peaked or reached a level suggestive of possible lethality (>41.5 degrees C), rats were injected with Evans blue (EB), rapidly anesthetized, perfused, and their brains were taken for further analyses. Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na(+), K(+), Cl(-)) contents, immunostained for albumin and glial fibrillary acidic protein (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy. These examinations revealed profound abnormalities in neuronal, glial, and endothelial cells, which were stronger with METH administered at 29 degrees C than 23 degrees C and tightly correlated with brain and body hyperthermia. These changes had some structural specificity, but in each structure they tightly correlated with increases in EB levels, the numbers of albumin-positive cells, and water and ion contents, suggesting leakage of the BBB, acutely developing brain edema, and serious shifts in brain ion homeostasis as leading factors underlying brain abnormalities. While most of these acute structural and functional abnormalities appear to be reversible, they could trigger subsequent cellular alterations in the brain and accelerate neurodegeneration-the most dangerous complication of chronic amphetamine-like drug abuse.
Sharma
Hari S
HS
Laboratory of Cerebrovascular Research, Department of Surgical Sciences, University Hospital, Uppsala University, SE-751 85 Uppsala, Sweden. Sharma@surgsci.uu.se
Kiyatkin
Eugene A
EA
D000418:Albumins / Q000378:metabolism; D000818:Animals; D001812:Blood-Brain Barrier / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D001929:Brain Edema / Q000139:chemically induced; D002199:Capillary Permeability; D000697:Central Nervous System Stimulants / Q000633:toxicity*; D004573:Electrolytes / Q000378:metabolism; D042783:Endothelial Cells / Q000648:ultrastructure; D004730:Endothelium, Vascular / Q000648:ultrastructure; D004847:Epithelial Cells / Q000473:pathology / Q000648:ultrastructure; D005334:Fever / Q000139:chemically induced; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D008297:Male; D008694:Methamphetamine / Q000633:toxicity*; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009457:Neuroglia / Q000473:pathology; D009474:Neurons / Q000473:pathology / Q000648:ultrastructure; D051381:Rats; D020318:Rats, Long-Evans; D014157:Transcription Factors / Q000378:metabolism
D000418:Albumins; D000697:Central Nervous System Stimulants; D004573:Electrolytes; D005904:Glial Fibrillary Acidic Protein; C436006:Mbp protein, rat; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D014157:Transcription Factors; D008694:Methamphetamine
Eur J Pharmacol. 2000 Dec 15;409(3):265-71
11108820
Pharmacol Biochem Behav. 1990 Aug;36(4):745-9
2217500
Restor Neurol Neurosci. 1995 Jan 1;7(4):207-15
21551791
Neurochem Res. 2003 Aug;28(8):1163-73
12834255
Eur J Neurosci. 2007 Sep;26(5):1242-53
17767502
Neurosci Lett. 2004 Sep 9;367(3):349-54
15337264
Prog Brain Res. 1998;115:351-412
9632943
Crit Rev Neurobiol. 2005;17(2):87-117
16808729
Ann N Y Acad Sci. 2006 Aug;1074:198-224
17105918
J Pharmacol Exp Ther. 1994 Mar;268(3):1571-80
8138969
J Pharmacol Exp Ther. 1994 Aug;270(2):741-51
8071867
Synapse. 2006 Dec 1;60(7):521-32
16952162
J Pharmacol Exp Ther. 2006 Mar;316(3):1210-8
16293712
Prog Brain Res. 1992;91:189-96
1410403
Acta Neurochir Suppl (Wien). 1990;51:383-6
2089947
Neurobiol Aging. 2003 May-Jun;24 Suppl 1:S123-7; discussion S131
12829120
J Pharmacol Exp Ther. 1994 Aug;270(2):752-60
8071868
Pain. 2006 Sep;124(1-2):211-21
16806707
J Neurosurg. 1977 Oct;47(4):525-31
903805
Neuroscience. 1992 Jun;48(4):889-901
1630627
Am J Physiol. 1988 Feb;254(2 Pt 2):H286-91
3344819
Am J Physiol Regul Integr Comp Physiol. 2000 May;278(5):R1240-6
10801293
Indian J Med Res. 2006 May;123(5):629-52
16873906
J Pharm Pharmacol. 1976 Feb;28(2):162-3
6680
Sheng Wu Gong Cheng Xue Bao. 2007 May;23(3):471-6
17577996
Prog Brain Res. 1998;115:241-74
9632939
Acta Neuropathol. 1993;85(2):145-53
8442406
Ann N Y Acad Sci. 1996 Oct 31;801:187-98
8959033
Neurochem Res. 1992 Sep;17(9):877-85
1407275
Neurotox Res. 2007 Apr;11(3-4):183-202
17449459
Brain Res Brain Res Rev. 2005 Dec 1;50(1):27-56
15890410
Brain Res Dev Brain Res. 1990 Oct 1;56(1):47-53
2279331
Eur J Pharmacol. 1998 Dec 18;363(2-3):107-12
9881575
J Pharmacol Exp Ther. 1995 Dec;275(3):1104-14
8531070
Amino Acids. 2002;23(1-3):261-72
12373546
Ann N Y Acad Sci. 1993 May 28;679:195-210
8512183
Spinal Cord. 2003 Jul;41(7):369-78
12815368
Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(7):1016-20
4041105
Radiat Res. 1991 Apr;126(1):43-51
1850533
Neurotox Res. 2005 Nov;8(3-4):199-206
16371314
Hum Cell. 1996 Dec;9(4):353-66
9183669
Environ Res. 2003 May;92(1):48-53
12706754
Brain Res. 1980 Jul 7;193(1):153-63
7378814
Ann N Y Acad Sci. 1997 Mar 15;813:572-80
9100936
Int J Hyperthermia. 2003 May-Jun;19(3):325-54
12745974
Experientia. 1975 Dec 15;31(12):1436-7
1213067
NIDA Res Monogr. 1996;163:251-76
8809863
J Neurosci. 2003 May 1;23(9):3924-9
12736362
Glia. 2001 Apr 15;34(2):134-42
11307162
Int J Hyperthermia. 2000 Jan-Feb;16(1):73-83
10669318
Can Med Assoc J. 1975 Feb 8;112(3):299-304
1089034
Di Yi Jun Yi Da Xue Xue Bao. 2003 Jan;23(1):21-4
12527507